In line with results concerning other EGFR-targeted TKIs in NSCLC, erlotinib also elicits cytotoxicity via oxidative stress generation in head and neck squamous cell carcinoma (HNSCC) cell lines, again being reversible with N-acetyl cysteine [51]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.